INTRODUCTION
Group A beta-hemolytic Streptococcus (GAS) is the most common infectious agent responsible for acute glomerulonephritis in children, but other infectious agents and other Streptococci can be involved, such as Streptococcus pneumoniae (1) and
Lancefield group G and C Streptococci (S. zooepidermicus)^^1. Over 470,000 cases of acute poststreptococcal glomerulonephritis (APSGN) occur annually, leading to approximately 5000 deaths; 97% of these cases occur in less well-developed countries (3) .
Crescentic glomerulonephritis is the histopathologic correlate of the clinically defined condition of rapidly progressive glomerulonephritis (RPGN). It is relatively rare in childhood and is characterized by the presence of extensive crescents demonstrable on renal biopsy and by sudden and progressive decline in renal function over days or weekst 4) . In most pediatric studies of crescentic glomerulonephritis (CGN) or RPGN, post-infectious or acute poststreptococcal glomerulonephritis (APSGN) constitute a small proportion of cases.
In one of the largest pediatric series of CON, the South West Pediatric Nephrology Study Group reported 50 children with CON, of whom only six were due to APSGNt 5) . In another series of CGN by Jardim (ы only two of 30 children had APSGN as the primary diagnosis. In these two series vasculitides due to HenochSchonlein purpura or systemic lupus erythematosus were collectively the most common cause of CON. In contrast, our experience, like recent data of Wong et a1.
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has been very different, with APSGN being the leading cause of crescentic or rapidly progressive glomerulonephritis, In this retrospective study from New Zealand, the authors examined the characteristics and treatment of acute PSGN in 27 pediatric patients. The authors pointed out that PSGN is the most frequent cause of severe acute GN among children in New Zealand, with children of either Pacific Island or Maori ethnicity making up 85% of PSGN patients. The authors found also that the need for acute dialysis was most common among the 11 children in the study with crescentic GN.
They also determined that urinary sediment abnormalities persisted in the patients with crescentic GN even after a mean follow-up period of 3.2 years and that the benefits of immunosuppressive therapy were unclear in these patients.
AIM OF THE WORK
In this study we aim to look at the outcome of pediatric patients admitted or referred to us diagnosed as post streptococcal rapidly progressively glomerulonephritis.
PATIENTS AND METHODS
In this retrospective study we have included all pediatric patients with crescentic glomerulonephritis following acute post-streptococcal glomerulonephritis admitted or referred from other hospitals to our institute (King Abdulaziz University Hospital, Jeddah, KSA) between January 2003 and May 2009. The patients selection criteria were: 1-Those with clinical and laboratory evidence of rapidly progressive glomerulonephritis that was proven to be crescentic glomerulonephritis by renal biopsy 2-Have an evidence of poststreptococcal infection.
The diagnostic criteria for APSGN were: 1-Elevated streptococcal titers, 2-Transiently depressed C3 complement; 3-Absence of past history of chronic renal disease. The diagnosis of APSGN was made if the patients' clinical and laboratory findings and subsequent progression of the symptoms were consistent with the disease.
Crescentic glomerulonephritis was defined as the presence of large epithelial crescents filling the Bowman's spaces in 50% or more glomeruli on biopsy. A11 patients were subjected to: Indications for renal biopsy were: 1-Anuric renal failure; 2-Rapid rise of creatinine more than fourfold higher than upper limit or normal within 1-2 weeks of presentation; 3-Mixed nephritic nephrotic syndrome; 4-Delay in recovery of renal function within 2-3 weeks after the onset of acute nephritis, 5-Persistent gross hematuria for more than 2 weeks. Nephrotic range proteinuria was defined as either +3 or more protein on dipstick testing or a urine protein to creatinine ratio greater than 200 mg/mmol.
All patients had a renal biopsy evaluated by expert pathologists who were blind to clinical outcome. The tissue biopsies were studied by light, immunofluorescence and electron microscopy. For light microscopy Paraffin-embedded renal sections were stained with trichrome, silver, periodic acid-Schiff and haematoxylin/ eosin. The IF studies were performed by a classic direct IF technique using antibodies against IgA, IgG, IgM, С3 and C l q.
The following features were evaluated: Total number of glomeruli, number of glomeruli with crescents, type of crescents. 
RESULTS
When we started to collect our data we found a total of 13 cases of RPGN due to different etiologies. Three out of them were excluded from our study. One of them showed both the clinical and laboratory criteria of poststreptococcal RPGN but renal biopsy never been done because of family refusal so, not proven to be crescentic GN.
The two other cases had no evidence of post streptococcal etiology; one of them was 15 months old girl. Her renal biopsy revealed MPGN-1 (membranoproliferative glomerulonephritis type-1) with 70°/о fibrous crescents. This patient died in the PICU after doing CVVHD. The other patient was a 2 yr old boy who presented with generalized body edema, severe hypertension, nephrotic range proteinuria, rapid rise of his serum creatinine and his renal biopsy again revealed MPtiN-1 with 100% cellular crescents. This patient received various immunosuppressive regimens including, methyleprednisolone, I.V cyclophosphamide and finally rituximab (anti-CD20 anti-body) with deterioration of his kidney function that needed regular dialysis support. Currently he is on CAPD. Tables (1 and 2) show demographics, biochemical and serologic features of the patients at presentation.
Descriptive analysis:
We studied 10 patients. All of them were diagnosed as having post streptococcal crescentic glomerulonephritis based on clinical presentation, laboratory evidence of preceding streptococcal infection and biopsy results. Six of them were males (60%) and 4 were females (40°/о), so M/F ratio was 1:0.66. The mean age at the time of presentation was 8.4 years with a range of 4 to 11 years.
All were having gross hematuria, progressive rise of serum creatinine. Eight patients were having hypertension (80%) 5 of them were males (63%) and 3 were females (37%) the remaining two normotensive patients (20%) were one male and one female. The mean duration of symptoms before performing biopsy was 21 days with range 15-28 days. The mean of highest creatinine was 563 umol/1 with range of (396-870). Five out of 10 (50%) were having nephrotic range of proteinuria and remaining were having moderate range.
Interestingly 4 out of the 5 patients with nephrotic range were males (80%). The mean serum albumin for the 10 patients was 20 g/1 at presentation. In those with nephrotic range proteinuria the mean albumin was 14.6 g/1 at presentation. Two of the patients with nephrotic range proteinuria had fibrocellular crescents in renal biopsy and the other 3 had cellular crescents.
All the patients had an evidence of preceding streptococcal infection, ASO titer mean was 743 with range of (450-1500).
All 10 patients had low С3 (100%). No patient had reduced C4 complement. Eight patients (80%) were having history of URTI, one had history of preceding skin infection (10%), and one had no evidence of clinical infection before their presentation (10%). Anti-DNAse-B was positive for 9 patients and unfortunately result was not found for the 10 t " patient. None of the 10 patients were having positive antinuclear antibodies ANA, anti neutrophil cytoplasmic antibodies pANCA or cANCA or anti glomerular basement membrane (anti GBM) test. Hepatitis B serology was negative for all patients. Table ( 3) shows renal biopsy results. All our 10 patients went to renal biopsy which revealed > 50% crescents in all biopsies with mean of 62.5% and ranging between 50-88%. Two patients had fibrocellular crescents (20%) and 
DISCUSSION
Most patients of APSGN, particularly children, have an excellent outcome (9) . This is true even in patients who present with acute renal failure and may have crescents on the initial renal biopsy. A review of three case series of 229 children with PSGN found that approximately 20 percent had an abnormal urinalysis (proteinuria and/or hematuria), but almost all (92 to 99 percent) had normal or only modestly reduced renal function 5 to 18 years after presentation (9) .
However, the long-term prognosis of PSGN is not always benign ( °). Some patients, particularly adults (11) , develop hypertension, recurrent proteinuria, and renal insufficiency as long as 10 to 40 years after the initial illness (12) .
In this retrospective study we describe the outcome of 10 patients crescentic poststreptococcal glomerulonephritis admitted or referred from other hospitals to our institute (KAUH) between January 2003 and May 2009. We found a total of 13 cases of crescentic glomerulonephritis (CsGN) due to different etiologies. Ten of them (70%) showed both the clinical and laboratory criteria of poststreptococcal (CsGN). El-Husseini et al. (2003) noticed that the prevalence of CON among 128 Egyptian patients is somewhat different from that reported in Western literature: post-infectious GN is higher than that reported in other series this might be attributed to the endemicity of some infections such as streptococcal infection in our locality and possibly due to racial factors^1
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• In a recent Indian study by Gulati et al. immune complex glomerulonephritis was the commonest etiology of crescentic glomerulonephritis in children, (86.4%), and the majority of these children had postinfectious glomerulonephritis (1 4) .
The etiology in our study is in concordance with the findings in both studies and other studies (6,1 5) wherein immune-complex glomerulonephritis accounted for the majority of the case. In contrast, Miller et al. observed that most children in their series had well-defined systemic or primary glomerular disease, and only two of the 56 patients with a crescentic lesion had disease that had a definite post-streptococcal etiology (16) . months. Hence, the majority of his patients had severe disease at presentation and 15/22 (68%) were dialysis dependent at presentation. Late referral may be related to the fact that his institute is a tertiary care hospital (14) . In contrast to our study where is early referral and early diagnosis as the mean duration of symptoms before performing biopsy was 21 days with range 15-28 days. However, acute dialysis support was needed in б patients (60%).
All our 10 patients had low CЗ (100%); Crescentic PSAGN may have an increased association with normocomplementemia in some studies, Fїve of the 10 crescentic PSAGN patients from Memphis (17) and four of 11 from New Zealand (7) had normal or near-normal serum C3 levels; however, none of the four reported by Lewy et аl.
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had normal or near-normal serum CЗ levels.
The reason for this possible association of normocomplementemia with crescent formation in PSAGN is not clear.
All of the 10 patients had б doses of IV methyleprednisolone 600 mg/m 2 followed by 2 month course of oral cyclophos- It is important to note that poststreptococcal crescentic glomerulonephritis may carry a better prognosis than crescent formation of other etiology. In our study, 8 patients regained their normal kidney functions (80%) with mean creatinine 46 mmol/1 ranging between (39-66 p value < 0.00 1 "). Eight patients (80%) became normotensїve at last follow up visits (p value < 0.00l**). Two patients out of 10 (20%) had residual renal impairment; the serum creatinine of one of them (patient #6)_ was122 mmol/1 after 32 months follow up and his calculated GFR was 41 ml/min. This patient was still also having residual hypertension needing double antihypertensives to be controlled and residual subnephrotic range proteinuria (+1 urine dipstick) on antiproteinuric agent (Enalapril). 'Of note, this patient had fibrocellular crescents in the renal biopsy and was referred to us 3 weeks after symptoms. This is one of 2 patients (patient #5 and #6) still having hypertension (20%) that needed medical treatment. Interestingly the 2 patients had fibro cellular crescents in renal biopsy. The 2nd patient with residual mild kidney dysfunction (patient #4) had last s. creatinine of 80 mmоl/1 and his calculated GFR was 65 ml/min. i.e. stage 2 CKD. Interestingly, the percentage of glomeruli with cellular crescents was very high (75%). (22) have shown a positive correlation between the percentage of glomeruli affected by crescent formation and the progression to end stage renal failure they confirmed that the more extensive the crescent formation, the less there is a chance of recovery of renal function, and the poor prognosis of patients with post infectious CON when there is persistent nephrotic range proteinuria or hypertension (б) . El-Husseini et al. (13) demonstrated that the percentage of fibrous crescent had a significant impact on kidney function at last follow-up. This is in accordance to that reported by Atkins et al. They reported that the presence of acute cellular crescent is more indicative of a likely positive response to immunosuppressive treatment and anticoagulants than diseases in which crescents are undergoing fibrosis (23) . In the study of Gulati et al. they
reported, the high incidence of advanced renal failure was also histopathologically correlated by the high frequency of chronicity changes seen on kidney biopsy, as evidenced by the presence of fibrocellular crescents in the majority of the patients [(14/22, 64%)] and the presence of glomerular sclerosis in a significant number of children [(10/22, 45%)) at presentation (141 . These findings were almost similar to those in the study by the Southwest Pediatric Nephrology Study Group, where it was observed that only 37% of the crescents were cellular, while the majority (63%)
were fibrous/fibrocellular crescentst 5) .
In conclusion, the overall outcome of our 10 patients with poststreptococcal crescentic glomerulonephritis was excellent; 8 patients out of 10 i.e. (80%) regained their normal kidney functions and 8 patients (80%) became normotensive at last follow up visits. Due to the limited number of our patients, a large multi-centre study is recommended to prove these results and to assess the benefits of immunosuppression.
